We have developed a vaccine strategy for generating an attenuated strain of an intracellular bacterial pathogen that, after uptake by professional antigen-presenting cells, does not replicate intracellularly and is readily killed. However, after degradation of the vaccine strain within the phagolysosome, target antigens are released into the cytosol for endogenous processing and presentation for stimulation of CD8+ effector T cells.
Applying this strategy to the model intracellular pathogen Listeria monocytogenes, we show that an intracellular replication-deficient vaccine strain is cleared rapidly in normal and immunocompromised animals, yet antigen-specific CD8+ effector T cells are stimulated after immunization. Furthermore, animals immunized with the intracellular replication-deficient vaccine strain are resistant to lethal challenge with a virulent WT strain of L. monocytogenes. These studies suggest a general strategy for developing safe and effective, attenuated intracellular replication-deficient vaccine strains for stimulation of protective immune responses against intracellular bacterial pathogens.
Published online before print March 20, 2006, 10.1073/pnas.0509381103 PNAS | March 28, 2006 | vol. 103 | no. 13 | 5102-5107
*Immunology Research, Earle A. Chiles Research Institute and Veterans Affairs Medical Center, Portland, OR 97239; and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115
Edited by John J. Mekalanos, Harvard Medical School, Boston, MA, and approved February 8, 2006 (received for review October 27, 2005)
Author contributions: H.G.A.B. and D.E.H. designed research; H.G.A.B., C.A.-S., M.J.M., and D.E.H. performed research; N.D.B. and D.E.H. contributed new reagents/analytic tools; H.G.A.B., C.A.-S., M.J.M., and D.E.H. analyzed data; and H.G.A.B. and D.E.H. wrote the paper. Conflict of interest statement: No conflicts declared.
To whom correspondence should be addressed. E-mail: dhiggins@hms.harvard.edu